Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers (original) (raw)

Melanoma and immunotherapy bridge 2015

Angel Rivera

Journal of Translational Medicine, 2016

View PDFchevron_right

Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts

Genny Del Zotto

Journal of Translational Medicine, 2018

View PDFchevron_right

Immunotherapy Bridge 2016 and Melanoma Bridge 2016: meeting abstracts

Vincenzo Montesarchio

Journal of Translational Medicine

View PDFchevron_right

Medical Immunosuppression and Outcomes in Cutaneous Melanoma: A Population-Based Cohort Study

Janice Austin

Annals of Surgical Oncology, 2020

View PDFchevron_right

Prognostic value of quantitative immune alterations in melanoma patients

A. Tres

Oncología (Barcelona), 2006

View PDFchevron_right

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma

Giuseppe Palmieri

Frontiers in Oncology

View PDFchevron_right

Outcomes of Immunosuppressed Patients Who Develop Melanoma: A Population-Based Propensity-Matched Cohort Study

Janice Austin

Annals of Surgical Oncology, 2020

View PDFchevron_right

Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring

Monica Neagu

Current Proteomics, 2013

View PDFchevron_right

Cancer immunotherapy: present scenarios and the future of immunotherapy

Gaurisankar Sa

The Nucleus, 2019

View PDFchevron_right

Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008

Wolfram Samlowski, Sancy Leachman

Pigment Cell & Melanoma Research, 2009

View PDFchevron_right

Immunotherapy Outcomes in Advanced Melanoma in Relation to Age

Issam Makhoul

The Permanente Journal, 2020

View PDFchevron_right

Future perspectives in melanoma research. Meeting report from the “Melanoma Bridge. Napoli, December 2nd-4th 2012”

Ena Wang

Journal of Translational Medicine, 2013

View PDFchevron_right

Immunotherapy: breakthrough in Cancer Treatment

Mrs. Reshmi Gopalakrishnan

2023

View PDFchevron_right

Immunologic escape and angiogenesis in human malignant melanoma

Pedro Redondo

Journal of the American Academy of Dermatology, 2003

View PDFchevron_right

Cancer Immunotherapy: A breakthrough in patient care

Abdallah Badou

Health Sciences, 2022

View PDFchevron_right

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Roberta Zappasodi

Journal for ImmunoTherapy of Cancer, 2016

View PDFchevron_right

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

Luis Real

Cancer Immunology, Immunotherapy, 2001

View PDFchevron_right

Predictive factors of response to immunotherapy—a review from the Spanish Melanoma Group (GEM)

Ainara Soria

Annals of Translational Medicine, 2017

View PDFchevron_right

Vitiligo-like leukoderma as an indicator of clinical response to immune checkpoint inhibitors in late-stage melanoma patients

Cristina Fortes

Journal of Cancer Research and Clinical Oncology, 2021

View PDFchevron_right

Current and emerging treatment options for uveal melanoma

Li-anne Lim

Clinical Ophthalmology, 2013

View PDFchevron_right

Tumor screening and biology in malignant melanomas

Salvador J Diaz-Cano

2000

View PDFchevron_right

Genes and signaling pathways affecting the pathogenesis of melanoma

Bridget Varughese

Postdoc Journal, 2013

View PDFchevron_right

Cell-based vaccination against melanoma – background, preliminary results, and perspective

Dirk Schadendorf

Journal of Molecular Medicine, 1999

View PDFchevron_right

Aspects of cancer immunotherapy

Bruce Loveland

Immunology and Cell Biology, 2003

View PDFchevron_right

Immunotherapy: A Novel Approach to Fight Cancer

Fateh Singh

International Journal of Current Microbiology and Applied Sciences, 2020

View PDFchevron_right

Clinical status of diagnosis and therapy of malignant melanoma

Alessandro Testori

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1989

View PDFchevron_right

Melanocyte differentiation antigen RAB38/NY-MEL-1 induces frequent antibody responses exclusively in melanoma patients

asma gati

Cancer Immunology, Immunotherapy, 2006

View PDFchevron_right

UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma

Lea Eisenbach

Cell, 2019

View PDFchevron_right

Cancer Immunotherapy: A Systemic Review

Ashesh Chowdhury

Archives of oncology and cancer therapy, 2024

View PDFchevron_right

Immunological Insights from Patients Undergoing Surgery on Ipilimumab for Metastatic Melanoma

Mary Brady

Annals of Surgical Oncology, 2013

View PDFchevron_right

Cancer Immunology and Immunotherapy – Understanding and Adaptation the Current Evidence to Optimize Patient Therapy Outcomes

Orlin Savov

Journal of IMAB - Annual Proceeding (Scientific Papers), 2015

View PDFchevron_right

In Vivo Melanoma Cell Morphology Reflects Molecular Signature and Tumor Aggressiveness

Roberta Lotti

Journal of Investigative Dermatology, 2022

View PDFchevron_right

Malignant Melanoma in the 21st Century, Part 1: Epidemiology, Risk Factors, Screening, Prevention, and Diagnosis

Ravi Dama

Mayo Clinic Proceedings, 2007

View PDFchevron_right

Identification of new genes associated with melanoma

Thomas Stempfl

Experimental Dermatology, 2011

View PDFchevron_right

Linking Transcriptomic and Imaging Data Defines Features of a Favorable Tumor Immune Microenvironment and Identifies a Combination Biomarker for Primary Melanoma

Luke barker

Cancer Research, 2020

View PDFchevron_right